Glibenclamide ameliorates the expression of neurotrophic factors in sevoflurane anaesthesia-induced oxidative stress and cognitive impairment in hippocampal neurons of old rats

1Alizadeh-Fanalou S., Babaei M., Hosseini A., Azadi N., Ali Nazarizadeh N., Shojaii A., Borji M., Malekinejad H., Bahreini E.: Effects of Securigera Securidaca seed extract in combination with glibenclamide on antioxidant capacity, fibroblast growth factor 21 and insulin resistance in hyperglycemic rats. J Ethnopharmacol 2020, 248, 112331, doi: 10.1016/j.jep.2019.112331. Alizadeh-Fanalou S. Babaei M. Hosseini A. Azadi N. Ali Nazarizadeh N. Shojaii A. Borji M. Malekinejad H. Bahreini E. Effects of Securigera Securidaca seed extract in combination with glibenclamide on antioxidant capacity, fibroblast growth factor 21 and insulin resistance in hyperglycemic rats J Ethnopharmacol 2020 248 112331 10.1016/j.jep.2019.112331Open DOISearch in Google Scholar

2Allard J.S., Perez E.J., Fukui K., Carpenter P., Ingram D.K., de Cabo R.: Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice. Behav Brain Res 2016, 301, 1–9, doi: 10.1016/j.bbr.2015.12.012. Allard J.S. Perez E.J. Fukui K. Carpenter P. Ingram D.K. de Cabo R. Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice Behav Brain Res 2016 301 1 9 10.1016/j.bbr.2015.12.012Open DOISearch in Google Scholar

3Amani M., Zolghadrnasab M., Salari A.-A.: NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease. Physiol Behav 2019, 202, 52–61, doi: 10.1016/j.physbeh.2019.01.005. Amani M. Zolghadrnasab M. Salari A.-A. NMDA receptor in the hippocampus alters neurobehavioral phenotypes through inflammatory cytokines in rats with sporadic Alzheimer-like disease Physiol Behav 2019 202 52 61 10.1016/j.physbeh.2019.01.005Open DOISearch in Google Scholar

4Arnold S.E., Arvanitakis Z., Macauley-Rambach S.L., Koenig A.M., Wang H.-Y., Ahima R.S., Craft S., Gandy S., Buettner C., Stoeckel L.E., Holtzman D.M., Nathan D.M.: Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nat Rev Neurol 2018, 14, 168–181, doi: 10.1038/nrneurol.2017.185. Arnold S.E. Arvanitakis Z. Macauley-Rambach S.L. Koenig A.M. Wang H.-Y. Ahima R.S. Craft S. Gandy S. Buettner C. Stoeckel L.E. Holtzman D.M. Nathan D.M. Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums Nat Rev Neurol 2018 14 168 181 10.1038/nrneurol.2017.185Open DOISearch in Google Scholar

5Baglietto-Vargas D., Shi J., Yaeger D.M., Ager R., LaFerla F.M.: Diabetes and Alzheimer’s disease crosstalk. Neurosci Biobehav Rev 2016, 64, 272–287, doi: 10.1016/j.neubiorev.2016.03.005. Baglietto-Vargas D. Shi J. Yaeger D.M. Ager R. LaFerla F.M. Diabetes and Alzheimer’s disease crosstalk Neurosci Biobehav Rev 2016 64 272 287 10.1016/j.neubiorev.2016.03.005Open DOISearch in Google Scholar

6Baraka A., ElGhotny S.: Study of the effect of inhibiting galanin in Alzheimer’s disease induced in rats. Eur J Pharmacol 2010, 641, 123–127, doi: 10.1016/j.ejphar.2010.05.030. Baraka A. ElGhotny S. Study of the effect of inhibiting galanin in Alzheimer’s disease induced in rats Eur J Pharmacol 2010 641 123 127 10.1016/j.ejphar.2010.05.030Open DOISearch in Google Scholar

7Bedse G., Di Domenico F., Serviddio G., Cassano T.: Aberrant insulin signaling in Alzheimer’s disease: current knowledge. Front Neurosci 2015, 9, 204, doi: 10.3389/fnins.2015.00204. Bedse G. Di Domenico F. Serviddio G. Cassano T. Aberrant insulin signaling in Alzheimer’s disease: current knowledge Front Neurosci 2015 9 204 10.3389/fnins.2015.00204Open DOISearch in Google Scholar

8Biessels G.J., Strachan M.W.J., Visseren F.L.J., Kappelle L.J., Whitmer R.A.: Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2014, 2, 246–255, doi: 10.1016/S2213-8587(13)70088-3. Biessels G.J. Strachan M.W.J. Visseren F.L.J. Kappelle L.J. Whitmer R.A. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions Lancet Diabetes Endocrinol 2014 2 246 255 10.1016/S2213-8587(13)70088-3Open DOISearch in Google Scholar

9Brewster A.L., Lugo J.N., Patil V.V., Lee W.L., Qian Y., Vanegas F., Anderson A.E.: Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PLoS One 2013, 8, e57808, doi: 10.1371/journal.pone.0057808. Brewster A.L. Lugo J.N. Patil V.V. Lee W.L. Qian Y. Vanegas F. Anderson A.E. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage PLoS One 2013 8 e57808 10.1371/journal.pone.0057808359423223536771Open DOISearch in Google Scholar

10Brownlee M.: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54, 1615–1625, doi: 10.2337/diabetes.54.6.1615. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism Diabetes 2005 54 1615 1625 10.2337/diabetes.54.6.161515919781Open DOISearch in Google Scholar

11Chen F., Dong R.R., Zhong K.L., Ghosh A., Tang S.S., Long Y., Hu M., Miao M.X., Liao J.M., Sun H.B., Kong L.Y., Hong H.: Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice. Neuropharmacology 2016, 101, 123–136, doi: 10.1016/ j.neuropharm.2015.07.023. Chen F. Dong R.R. Zhong K.L. Ghosh A. Tang S.S. Long Y. Hu M. Miao M.X. Liao J.M. Sun H.B. Kong L.Y. Hong H. Antidiabetic drugs restore abnormal transport of amyloid-β across the blood–brain barrier and memory impairment in db/db mice Neuropharmacology 2016 101 123 136 10.1016/j.neuropharm.2015.07.02326211973Open DOISearch in Google Scholar

12Chornenkyy Y., Wang W.-X., Wei A., Nelson P.T.: Alzheimer’s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline. Brain Pathol 2019, 29, 3–17, doi: 10.1111/bpa.12655. Chornenkyy Y. Wang W.-X. Wei A. Nelson P.T. Alzheimer’s disease and type 2 diabetes mellitus are distinct diseases with potential overlapping metabolic dysfunction upstream of observed cognitive decline Brain Pathol 2019 29 3 17 10.1111/bpa.12655642791930106209Open DOISearch in Google Scholar

13Chong Z.Z., Shang Y.C., Zhang L., Wang S., Maiese K.: Mammalian target of rapamycin: hitting the bull’s-eye for neurological disorders. Oxid Med Cell Longev 2010, 3, 374–391, doi: 10.4161/oxim.3.6.14787. Chong Z.Z. Shang Y.C. Zhang L. Wang S. Maiese K. Mammalian target of rapamycin: hitting the bull’s-eye for neurological disorders Oxid Med Cell Longev 2010 3 374 391 10.4161/oxim.3.6.14787315404721307646Open DOISearch in Google Scholar

14Correia S.C., Santos R.X., Carvalho C., Cardoso S., Candeias E., Santos M.S., Oliviera C.R., Moreira P.I.: Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation. Brain Res 2012, 1441, 64–78, doi: 10.1016/j.brainres.2011.12.063. Correia S.C. Santos R.X. Carvalho C. Cardoso S. Candeias E. Santos M.S. Oliviera C.R. Moreira P.I. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer’s disease and diabetes interrelation Brain Res 2012 1441 64 78 10.1016/j.brainres.2011.12.06322290178Open DOISearch in Google Scholar

15Costa A., Peppe A., Carlesimo G.A., Zabberoni S., Scalici F., Caltagirone C., Angelucci F.: Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson’s disease patients with mild cognitive impairment. Front Behav Neurosci 2015, 9, 253, doi: 10.3389/fnbeh.2015.00253. Costa A. Peppe A. Carlesimo G.A. Zabberoni S. Scalici F. Caltagirone C. Angelucci F. Brain-derived neurotrophic factor serum levels correlate with cognitive performance in Parkinson’s disease patients with mild cognitive impairment Front Behav Neurosci 2015 9 253 10.3389/fnbeh.2015.00253456986026441580Open DOISearch in Google Scholar

16Dou J.-T., Chen M., Dufour F., Alkon D.L., Zhao W.-Q.: Insulin receptor signaling in long-term memory consolidation following spatial learning. Learn Mem 2015, 12, 646–655, doi: 10.1101/lm.88005. Dou J.-T. Chen M. Dufour F. Alkon D.L. Zhao W.-Q. Insulin receptor signaling in long-term memory consolidation following spatial learning Learn Mem 2015 12 646 655 10.1101/lm.88005135618416287721Open DOISearch in Google Scholar

17El Batsh M.M., El Batch M.M., Shafik N.M., Younos I.H.: Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats. Eur J Pharmacol 2015, 769, 297–305, doi: 10.1016/j.ejphar.2015.11.033. El Batsh M.M. El Batch M.M. Shafik N.M. Younos I.H. Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats Eur J Pharmacol 2015 769 297 305 10.1016/j.ejphar.2015.11.03326607467Open DOISearch in Google Scholar

18Fangfang Z., Yangjun L., Binbin Y., Zhiping H.: Neuroprotective potential of glibenclamide is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage. Brain Res Bull 2018, 142, 18–24, doi: 10.1016/j.brainresbull.2018.06.006. Fangfang Z. Yangjun L. Binbin Y. Zhiping H. Neuroprotective potential of glibenclamide is mediated by antioxidant and anti-apoptotic pathways in intracerebral hemorrhage Brain Res Bull 2018 142 18 24 10.1016/j.brainresbull.2018.06.00629933037Open DOISearch in Google Scholar

19Faul F., Erdfelder E., Buchner A., Lang A.-G.: Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav Res Methods 2009, 41, 1149–1160, doi: 10.3758/BRM.41.4.1149. Faul F. Erdfelder E. Buchner A. Lang A.-G. Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses Behav Res Methods 2009 41 1149 1160 10.3758/BRM.41.4.114919897823Open DOISearch in Google Scholar

20Gainey S.J., Kwakwa K.A., Bray J.K., Pillote M.M., Tir V.L., Towers A.E., Freund G.G.: Short-term high-fat diet (HFD) induced anxiety-like behaviors and cognitive impairment are improved with treatment by glyburide. Front Behav Neurosci 2016, 10, 156, doi: 10.3389/fnbeh.2016.00156. Gainey S.J. Kwakwa K.A. Bray J.K. Pillote M.M. Tir V.L. Towers A.E. Freund G.G. Short-term high-fat diet (HFD) induced anxiety-like behaviors and cognitive impairment are improved with treatment by glyburide Front Behav Neurosci 2016 10 156 10.3389/fnbeh.2016.00156498039627563288Open DOISearch in Google Scholar

21Hsu C.-C., Wahlqvist M.L., Lee M.-S., Tsai H.-N.: Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 2011, 24, 485–493, doi: 10.3233/JAD-2011-101524. Hsu C.-C. Wahlqvist M.L. Lee M.-S. Tsai H.-N. Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin J Alzheimers Dis 2011 24 485 493 10.3233/JAD-2011-10152421297276Open DOISearch in Google Scholar

22Jain V., Baitharu I., Prasad D., Ilavazhagan G.: Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation. PLoS One 2013, 8, e62235, doi: 10.1371/journal.pone.0062235. Jain V. Baitharu I. Prasad D. Ilavazhagan G. Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF/PI3K/GSK3β pathway coupled with CREB activation PLoS One 2013 8 e62235 10.1371/journal.pone.0062235366050123704876Open DOISearch in Google Scholar

23Khanfar M.A., AbuKhader M.M., Alqtaishat S., Taha M.O.: Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone. J Mol Graph Model 2013, 42, 39–49, doi: 10.1016/j.jmgm.2013.02.009. Khanfar M.A. AbuKhader M.M. Alqtaishat S. Taha M.O. Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone J Mol Graph Model 2013 42 39 49 10.1016/j.jmgm.2013.02.00923545333Open DOISearch in Google Scholar

24Kho R.A., Choi B.Y., Lee S.H., Hong D.K.,Lee S.H., Jeong H.J., Park K.-H., Song H.K., Choi H.C., Suh S.W.: Effects of Protocatechuic Acid (PCA) on Global Cerebral Ischemia–Induced Hippocampal Neuronal Death. Int J Mol Sci 2018, 19, 1420, doi: 10.3390/ijms19051420. Kho R.A. Choi B.Y. Lee S.H. Hong D.K.Lee S.H. Jeong H.J. Park K.-H. Song H.K. Choi H.C. Suh S.W. Effects of Protocatechuic Acid (PCA) on Global Cerebral Ischemia–Induced Hippocampal Neuronal Death Int J Mol Sci 2018 19 1420 10.3390/ijms19051420598375129747437Open DOISearch in Google Scholar

25Kobayashi K., Takemori K., Sakamoto A.: Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening. Brain Res 2007, 1185, 1–7, doi: 10.1016/j.brainres.2007.09.011. Kobayashi K. Takemori K. Sakamoto A. Circadian gene expression is suppressed during sevoflurane anesthesia and the suppression persists after awakening Brain Res 2007 1185 1 7 10.1016/j.brainres.2007.09.01117942082Open DOISearch in Google Scholar

26Kujawska M., Jodynis-Liebert J.: Polyphenols in Parkinson’s disease: A Systematic Review of In Vivo Studies. Nutrients 2018, 10, 642, doi: 10.3390/nu10050642. Kujawska M. Jodynis-Liebert J. Polyphenols in Parkinson’s disease: A Systematic Review of In Vivo Studies Nutrients 2018 10 642 10.3390/nu10050642598652129783725Open DOISearch in Google Scholar

27Li J., Deng J., Sheng W., Zuo Z.: Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice. Pharmacol Biochem Behav 2012, 101, 564–574, doi: 10.1016/j.pbb.2012.03.002. Li J. Deng J. Sheng W. Zuo Z. Metformin attenuates Alzheimer’s disease-like neuropathology in obese, leptin-resistant mice Pharmacol Biochem Behav 2012 101 564 574 10.1016/j.pbb.2012.03.002332780322425595Open DOISearch in Google Scholar

28Lu B., Nagappan G., Lu Y.: BDNF and synaptic plasticity, cognitive function, and dysfunction. In: Handbook of Experimtental Pharmacology, volume 220, edited by G.R. Lewin, B.D. Carter Springer, Berlin, 2014, pp. 223–250, doi: 10.1007/978-3-642-45106-5_9. Lu B. Nagappan G. Lu Y. BDNF and synaptic plasticity, cognitive function, and dysfunction In Handbook of Experimtental Pharmacology, volume 220 edited by Lewin G.R. Carter B.D. Springer Berlin 2014 pp 223 250 10.1007/978-3-642-45106-5_924668475Open DOISearch in Google Scholar

29Łuc M., Woźniak M., Helemejko M., Rymaszewska J.: Tackling Alzheimer’s disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents. Life Sci 2019, 231, 116483, doi: 10.1016/j.lfs.2019.05.039. Łuc M. Woźniak M. Helemejko M. Rymaszewska J. Tackling Alzheimer’s disease: Hypothetical synergism between anti-inflammatory and anti-diabetic agents Life Sci 2019 231 116483 10.1016/j.lfs.2019.05.03931102743Open DOISearch in Google Scholar

30Mittal K., Katare D.P.: Shared links between type 2 diabetes mellitus and Alzheimer’s disease: A review. Diabetes Metab Syndr 2016, 10 (2 Suppl 1), S144–S149, doi: 10.1016/j.dsx.2016.01.021. Mittal K. Katare D.P. Shared links between type 2 diabetes mellitus and Alzheimer’s disease: A review Diabetes Metab Syndr 2016 10 2 Suppl 1 S144 S149 10.1016/j.dsx.2016.01.02126907971Open DOISearch in Google Scholar

31Moran C., Phan T.G., Chen J., Blizzard L., Beare R., Venn A., Münch G., Wood A.G., Forbes J., Greenaway T.M., Pearson S, Srikanth V.: Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013, 36, 4036–4042, doi: 10.2337/dc13-0143. Moran C. Phan T.G. Chen J. Blizzard L. Beare R. Venn A. Münch G. Wood A.G. Forbes J. Greenaway T.M. Pearson S Srikanth V. Brain atrophy in type 2 diabetes: regional distribution and influence on cognition Diabetes Care 2013 36 4036 4042 10.2337/dc13-0143Open DOISearch in Google Scholar

32Ortega F.J., Jolkkonen J., Mahy N., Rodríguez M.J.: Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2013, 33, 356–364, doi: 10.1038/jcbfm.2012.166. Ortega F.J. Jolkkonen J. Mahy N. Rodríguez M.J. Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia J Cereb Blood Flow Metab 2013 33 356 364 10.1038/jcbfm.2012.166Open DOISearch in Google Scholar

33Osborne C., West E., Nolan W., McHale-Owen H., Williams A., Bate C.: Glimepiride protects neurons against amyloid-β-induced synapse damage. Neuropharmacology 2016, 101, 225–236, doi: 10.1016/j.neuropharm.2015.09.030. Osborne C. West E. Nolan W. McHale-Owen H. Williams A. Bate C. Glimepiride protects neurons against amyloid-β-induced synapse damage Neuropharmacology 2016 101 225 236 10.1016/j.neuropharm.2015.09.030Open DOISearch in Google Scholar

34Patil S.P., Jain P.D., Ghumatkar P.J., Tambe R., Sathaye S.: Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice. Neuroscience 2014, 277, 747–754, doi: 10.1016/j.neuroscience.2014.07.046. Patil S.P. Jain P.D. Ghumatkar P.J. Tambe R. Sathaye S. Neuroprotective effect of metformin in MPTP-induced Parkinson’s disease in mice Neuroscience 2014 277 747 754 10.1016/j.neuroscience.2014.07.046Open DOISearch in Google Scholar

35Pintana H., Apaijai N., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C.: Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats. Life Sci 2012, 91, 409–414, doi: 10.1016/j.lfs.2012.08.017. Pintana H. Apaijai N. Pratchayasakul W. Chattipakorn N. Chattipakorn S.C. Effects of metformin on learning and memory behaviors and brain mitochondrial functions in high fat diet induced insulin resistant rats Life Sci 2012 91 409 414 10.1016/j.lfs.2012.08.017Open DOISearch in Google Scholar

36Rafique M.B., Cameron S.D., Khan Q., Biliciler S., Zubair S.: Anesthesia for children with mitochondrial disorders: a national survey and review. J Anesth 2013, 27, 186–191, doi: 10.1007/s00540-012-1488-1. Rafique M.B. Cameron S.D. Khan Q. Biliciler S. Zubair S. Anesthesia for children with mitochondrial disorders: a national survey and review J Anesth 2013 27 186 191 10.1007/s00540-012-1488-1Open DOISearch in Google Scholar

37Roberts R.O., Knopman D.S., Przybelski S.A., Mielke M.M., Kantarci K., Preboske G.M., Senjem M.L., Pankratz V.S., Geda Y.E., Boeve B.F., Ivnik R.J., Rocca W.A., Petersen R.C., Jack C.R. Jr.: Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology 2014, 82, 1132–1141, doi: 10.1212/WNL.0000000000000269. Roberts R.O. Knopman D.S. Przybelski S.A. Mielke M.M. Kantarci K. Preboske G.M. Senjem M.L. Pankratz V.S. Geda Y.E. Boeve B.F. Ivnik R.J. Rocca W.A. Petersen R.C. Jack C.R. Jr. Association of type 2 diabetes with brain atrophy and cognitive impairment Neurology 2014 82 1132 1141 10.1212/WNL.0000000000000269Open DOISearch in Google Scholar

38Roriz-Filho J.S., Sá-Roriz T.M., Rosset I., Camozzato A.L., Santos A.C., Chaves M.L.F., Moriguti J.C., Roriz-Cruz M.: (Pre)diabetes, brain aging, and cognition. Biochim Biophys Acta 2009, 1792, 432–443, doi: 10.1016/j.bbadis.2008.12.003. Roriz-Filho J.S. Sá-Roriz T.M. Rosset I. Camozzato A.L. Santos A.C. Chaves M.L.F. Moriguti J.C. Roriz-Cruz M. (Pre)diabetes, brain aging, and cognition Biochim Biophys Acta 2009 1792 432 443 10.1016/j.bbadis.2008.12.003Open DOISearch in Google Scholar

39Stokum J.A., Keledjian K., Hayman E., Karimy J.K., Pampori A., Imran Z., Woo S.K., Gerzanich V., Simard J.M.: Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury. Behav Brain Res 2017, 333, 43–53, doi: 10.1016/j.bbr.2017.06.038. Stokum J.A. Keledjian K. Hayman E. Karimy J.K. Pampori A. Imran Z. Woo S.K. Gerzanich V. Simard J.M. Glibenclamide pretreatment protects against chronic memory dysfunction and glial activation in rat cranial blast traumatic brain injury Behav Brain Res 2017 333 43 53 10.1016/j.bbr.2017.06.038Open DOISearch in Google Scholar

40Wolfer D.P., Madani R., Valenti P., Lipp H.-P.: Extended analysis of path data from mutant mice using the public domain software Wintrack. Physiol Behav 2001, 73, 745–753, doi: 10.1016/S0031-9384(01)00531-5. Wolfer D.P. Madani R. Valenti P. Lipp H.-P. Extended analysis of path data from mutant mice using the public domain software Wintrack Physiol Behav 2001 73 745 753 10.1016/S0031-9384(01)00531-5Open DOISearch in Google Scholar

41Xiao H., Liu B., Chen Y., Zhang J.: Learning, memory and synaptic plasticity in hippocampus in rats exposed to sevoflurane. Int J Dev Neurosci 2016, 48, 38–49, doi: 10.1016/j.ijdevneu. 2015.11.001. Xiao H. Liu B. Chen Y. Zhang J. Learning, memory and synaptic plasticity in hippocampus in rats exposed to sevoflurane Int J Dev Neurosci 2016 48 38 49 10.1016/j.ijdevneu.2015.11.00126612208Open DOISearch in Google Scholar

42Yin X., Zhang X., Lv C., Li C., Yu Y., W., Han F.: Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia. Sci Rep 2015, 5, 14507, doi: 10.1038/srep14507. Yin X. Zhang X. Lv C. Li C. Yu Y.W. Han F. Protocatechuic acid ameliorates neurocognitive functions impairment induced by chronic intermittent hypoxia Sci Rep 2015 5 14507 10.1038/srep14507458851326419512Open DOISearch in Google Scholar

43Zhang D.-X., Jiang S., Yu L.-N., Zhang F.-J., Zhuang Q., Yan M.: The effect of sevoflurane on the cognitive function of rats and its association with the inhibition of synaptic transmission. Int J Clin Exp Med 2015, 8, 20853–20860. Zhang D.-X. Jiang S. Yu L.-N. Zhang F.-J. Zhuang Q. Yan M. The effect of sevoflurane on the cognitive function of rats and its association with the inhibition of synaptic transmission Int J Clin Exp Med 2015 8 20853 20860Search in Google Scholar

44Zhang T., Gu J., Wu L., Li N., Sun Y., Yu P., Wang Y., Zhang G., Zhang Z.: Neuroprotective and axonal outgrowth-promoting effects of tetramethyl pyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia. Neuropharmacology 2017, 118, 137–147, doi: 10.1016/j.neuropharm.2017.03.022. Zhang T. Gu J. Wu L. Li N. Sun Y. Yu P. Wang Y. Zhang G. Zhang Z. Neuroprotective and axonal outgrowth-promoting effects of tetramethyl pyrazine nitrone in chronic cerebral hypoperfusion rats and primary hippocampal neurons exposed to hypoxia Neuropharmacology 2017 118 137 147 10.1016/j.neuropharm.2017.03.02228342896Open DOISearch in Google Scholar

45Zheng Y., Ley S.H., Hu F.B.: Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 2018, 14, 88–98, doi: 10.1038/nrendo.2017.151. Zheng Y. Ley S.H. Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications Nat Rev Endocrinol 2018 14 88 98 10.1038/nrendo.2017.15129219149Open DOISearch in Google Scholar

46Zou Y., Zhou C., Xu H., Yu J., Ye P., Zhang H., Chen S., Zhao J., Le S., Cui J., Jiang L., Wu J., Xia J.: Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression. Life Sci 2020, 241, 117141, doi: 10.1016/j.lfs.2019.117141. Zou Y. Zhou C. Xu H. Yu J. Ye P. Zhang H. Chen S. Zhao J. Le S. Cui J. Jiang L. Wu J. Xia J. Glibenclamide ameliorates transplant-induced arteriosclerosis and inhibits macrophage migration and MCP-1 expression Life Sci 2020 241 117141 10.1016/j.lfs.2019.11714131811853Open DOISearch in Google Scholar